arrow
N

Núbia Boechat

fundação oswaldo cruz
H指数:34
被引数:4,149

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Cruzain Inhibitors for Chagas Disease: Anticorrelated Optimisation Landscapes and the Multiparametric Path to Clinical Candidates

克ruzain抑制剂用于恰加斯病:负相关优化景观与多参数临床候选药物路径

2026-06-140
OAAI
Discovery of [1,2,4]triazolo[1,5-a]pyrimidine-Imatinib Hybrids With Selective Cytotoxic Activity: A Mechanistically Divergent Series From Direct BCR-ABL1 Inhibition

发现具有选择性细胞毒活性的[1,2,4]三唑并[1,5-a]嘧啶-伊马替尼杂合体:一种与直接BCR-ABL1抑制机制不同的系列

2026-04-280
OAAI
Antiviral Activity of Pyrazolopyrimidine and Triazolopyrimidine Derivatives Against SARS-CoV-2 In Vitro: Identifying PZP25 as a Promising Scaffold

抗病毒活性:吡唑嘧啶和三唑嘧啶衍生物对SARS-CoV-2的体外抑制作用:鉴定PZP25为有前景的骨架

2026-03-181
OAAI
Discovery of new piperaquine hybrid analogs linked by triazolopyrimidine and pyrazolopyrimidine scaffolds with antiplasmodial and transmission blocking activities
2024-03-012
PRE
Anti-Trypanosoma cruzi Activity, Mutagenicity, Hepatocytotoxicity and Nitroreductase Enzyme Evaluation of 3-Nitrotriazole, 2-Nitroimidazole and Triazole Derivatives
2023-11-072
OAAI
Antiplasmodial, Trypanocidal, and Genotoxicity In Vitro Assessment of New Hybrid α,α-Difluorophenylacetamide-statin Derivatives
2023-05-244
OAAI
In vitro antiviral activity of the anti-HCV drugs daclatasvir and sofosbuvir against SARS-CoV-2, the aetiological agent of COVID-19
2021-04-2160
OA